## Pink Passport

Targeted drug therapy


| Condition | Drug Name | Chinese Name | Route of Administration | Side Effects |
|----------|-----------|--------------|-------------------------|-------------|
| CDK4/6 inhibitor: ER/PR positive, HER2 negative | Ribociclib (Kisqali) | Jia'anli | Oral | Leukopenia, liver function abnormalities, cardiac dysfunction, fatigue, nausea, diarrhea, hair loss, headache. |
| ADC antibody-drug conjugate (targeted + chemotherapy): Triple-negative breast cancer | Govitecan Sacituzumab (Trodelvy) |  | Oral | Nausea, vomiting, fatigue, hair loss, diarrhea, constipation, rash, anemia, leukopenia. |